Who owns ADC Therapeutics SA?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ADCT from SEC Form 13F filings across 113 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 113 institutions disclosed 80.7M shares of ADC Therapeutics SA worth $86.7M — about 52.1% of shares outstanding; the largest disclosed holder is Nantahala Capital Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
113
13F holders
$86.7M
value, 2026 filers
52.1%
of shares outstanding (80.7M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ADCT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 12.3M | $13.2M | 0.4% | 8% | +120.2% |
| 2 | Redmile Group, LLC | 11.5M | $12.3M | 0.8% | 7.4% | -25.5% |
| 3 | TCG Crossover Management, LLC | 11.4M | $12.2M | 0.3% | 7.3% | 0.0% |
| 4 | Prosight Management, LP | 7.8M | $8.4M | 1.4% | 5% | -5.7% |
| 5 | BlackRock, Inc. | 7.0M | $7.5M | 0.0% | 4.5% | +12.3% |
| 6 | Point72 Asset Management, L.P. | 3.6M | $3.9M | 0.0% | 2.4% | +7.9% |
| 7 | MORGAN STANLEY | 3.1M | $3.3M | 0.0% | 2% | -20.0% |
| 8 | MILLENNIUM MANAGEMENT LLC | 2.9M | $3.1M | 0.0% | 1.9% | -7.0% |
| 9 | CITADEL ADVISORS LLC | 2.1M | $2.2M | 0.0% | 1.3% | +413.7% |
| 10 | GOLDMAN SACHS GROUP INC | 1.9M | $2.0M | 0.0% | 1.2% | +15.8% |
| 11 | STATE STREET CORP | 1.7M | $1.8M | 0.0% | 1.1% | +7.6% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $1.5M | 0.0% | 0.9% | +20.1% |
| 13 | BANK OF AMERICA CORP /DE/ | 1.3M | $1.4M | 0.0% | 0.8% | -2.8% |
| 14 | VANGUARD PORTFOLIO MANAGEMENT LLC | 897,092 | $959,888 | 0.0% | 0.6% | -13.2% |
| 15 | TWO SIGMA INVESTMENTS, LP | 773,414 | $827,553 | 0.0% | 0.5% | +15.8% |
| 16 | Blue Owl Capital Holdings LP | 733,568 | $784,918 | 0.1% | 0.5% | 0.0% |
| 17 | D. E. Shaw & Co., Inc. | 719,320 | $769,672 | 0.0% | 0.5% | +195.8% |
| 18 | Opaleye Management Inc.NEW | 700,000 | $749,000 | 0.1% | 0.5% | new |
| 19 | AQR CAPITAL MANAGEMENT LLC | 658,125 | $704,193 | 0.0% | 0.4% | +176.9% |
| 20 | BNP PARIBAS FINANCIAL MARKETS | 652,849 | $698,548 | 0.0% | 0.4% | -24.1% |
| 21 | NORTHERN TRUST CORP | 594,025 | $635,607 | 0.0% | 0.4% | +7.6% |
| 22 | PLATINUM INVESTMENT MANAGEMENT LTD | 581,609 | $622,322 | 0.2% | 0.4% | -41.3% |
| 23 | PANAGORA ASSET MANAGEMENT INC | 572,816 | $612,913 | 0.0% | 0.4% | -17.1% |
| 24 | UBS Group AG | 520,293 | $556,714 | 0.0% | 0.3% | +13.4% |
| 25 | SCHRODER INVESTMENT MANAGEMENT GROUP | 418,782 | $431,345 | 0.0% | 0.3% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.